Exploring TELA Bio, Inc. (TELA) Investor Profile: Who’s Buying and Why?

Ever wondered who's investing in TELA Bio, Inc. (TELA) and, more importantly, why? As of 2024, key financial institutions have been making significant moves, shaping the company's investor profile. With a keen focus on soft-tissue reconstruction solutions, TELA Bio reported a 19% revenue increase in 2024, reaching $69.3 million, despite some fourth-quarter disruptions. But, with a 79.07% share price decline between April 2024 and April 2025, is this a dip worth buying? Join us as we dissect the major players, their stakes, and the factors driving their investment decisions, offering you a comprehensive look into TELA Bio's financial landscape.

TELA Bio, Inc. (TELA) Who Invests in [Company Name] and Why?

Understanding the investor profile of TELA Bio, Inc. (TELA) provides valuable insights into the market's perception of the company and its future prospects. As of April 2025, TELA Bio's investor base comprises a mix of retail, institutional, and hedge fund investors, each with their own motivations and strategies.

Key Investor Types:

• Institutional Investors: These entities hold a significant portion of TELA Bio's shares. As of December 31, 2024, institutional investors held a total of 28,010,323 shares. Major institutional shareholders include:
  • Essex Woodlands Management, Inc.
  • Nantahala Capital Management, LLC
  • Silverarc Capital Management, Llc
  • AIGH Capital Management LLC
  • Stonepine Capital Management, LLC
  • Vanguard Group Inc
  • DAFNA Capital Management LLC
  • VTSMX - Vanguard Total Stock Market Index Fund Investor Shares
  • Royce & Associates Lp
  • Pentwater Capital Management LP
• Retail Investors: According to FUTUBULL, retail investors account for 41% of TELA Bio's ownership.
• Hedge Funds: Hedge funds also have a presence in TELA Bio's investor base, though their activity can be dynamic.

Investment Motivations:

• Growth Prospects: TELA Bio operates in the medical technology sector, specializing in soft-tissue reconstruction solutions. The company's focus on innovative products like the OviTex Reinforced Tissue Matrix and OviTex PRS positions it for growth in the hernia repair and plastic reconstructive surgery markets. In 2024, TELA Bio reported a 19% revenue growth, reaching $69.3 million. The company projects a revenue growth of 23% to 27% for 2025.
• Market Position: TELA Bio has carved out a niche in the medical device market by focusing on cost-effective solutions and biocompatible materials. Its flagship product, OviTex, is known for its safety features, strength, and handling benefits. The company's strategic initiatives, such as expanding into European markets and launching new products like OviTex IHR, have strengthened its market position. Since its launch in mid-April 2024, OviTex IHR has sold over 1,200 units.

Investment Strategies:

• Long-Term Holding: Some institutional investors adopt a long-term holding strategy, maintaining their positions in TELA Bio for an extended period.
• Short-Term Trading: Given the stock's volatility, some investors may engage in short-term trading strategies to capitalize on price fluctuations. TELA Bio's stock has experienced significant volatility, with its 52-week range spanning from $1.08 to $6.36.
• Value Investing: Some analysts believe that TELA Bio's stock is undervalued, suggesting a potential upside for investors. Canaccord Genuity has a Buy rating on the stock, with a reduced price target of $7.00 from $12.00.

TELA Bio's financial performance in 2024 presents a mixed picture. While the company achieved a 19% revenue growth, its Q4 growth slowed to 4%. The gross margin decreased to 64% in Q4 2024 from 68% in Q4 2023. However, the company's net loss improved to $37.8 million for the full year 2024, compared to $46.7 million in 2023. As of the end of 2024, TELA Bio had $52.7 million in cash.

For further insights into TELA Bio's financial health, you might find this resource helpful: Breaking Down TELA Bio, Inc. (TELA) Financial Health: Key Insights for Investors

TELA Bio, Inc. (TELA) Institutional Ownership and Major Shareholders of TELA Bio, Inc. (TELA)

Institutional ownership in TELA Bio, Inc. (TELA) provides insights into the stability and investor confidence in the company. Examining the top institutional investors, changes in ownership, and the overall impact of these large entities can help understand the dynamics influencing TELA's stock price and strategic direction.

Information on TELA Bio, Inc.'s major shareholders and institutional ownership can be found in the company's filings and financial news sources. These sources offer details on which institutions hold the largest positions, and how their holdings have changed over time.

As of December 31, 2024, the top institutional holders of TELA Bio, Inc. (TELA) include:

• Vanguard Group Inc.
• BlackRock Fund Advisors
• RA Capital Management, L.P.
• State Street Corp
• Geode Capital Management, LLC

These firms represent a significant portion of TELA's outstanding shares, reflecting their investment decisions and outlook on the company's prospects.

Changes in institutional ownership can indicate shifts in sentiment towards TELA Bio, Inc. (TELA). Increases in holdings may suggest growing confidence in the company's future performance, while decreases could signal concerns or strategic portfolio adjustments.

Recent data indicates the following changes in ownership:

• Some institutions have increased their positions, reflecting a bullish outlook.
• Others have reduced their stakes, potentially due to profit-taking or reassessment of risk.
• Overall, the trend shows a mix of adjustments as institutions refine their investment strategies.

The role of institutional investors in TELA Bio, Inc. (TELA) is substantial. Their trading activity can influence stock price volatility, and their long-term holdings often support the company's strategic initiatives. The presence of reputable institutional investors can enhance investor confidence and attract further investment.

The collective decisions of these major shareholders can impact TELA's stock performance and strategic direction. Monitoring these ownership trends is crucial for understanding market sentiment and potential future movements in the company's valuation.

For more in-depth information about TELA Bio, Inc., you can explore this resource: TELA Bio, Inc. (TELA): History, Ownership, Mission, How It Works & Makes Money

Below is a table summarizing key institutional ownership data for TELA Bio, Inc. (TELA):

Disclaimer: The data provided in the table is based on estimates for the fiscal year 2024 and may vary. Always refer to the latest SEC filings and official financial reports for the most accurate information.

TELA Bio, Inc. (TELA) Key Investors and Their Impact on TELA Bio, Inc. (TELA)

Understanding the investor profile of TELA Bio, Inc. (TELA) provides crucial insights into the company's stability, growth potential, and market sentiment. Examining who is investing in TELA and their recent activities can shed light on the factors driving the stock's performance and the company's strategic direction.

While specific, real-time major investor holdings and recent moves can fluctuate and may require up-to-the-minute financial data services to capture, we can discuss generally the types of investors and their potential impact based on standard investment practices.

Institutional investors often hold significant stakes in publicly traded companies like TELA Bio, Inc. (TELA). These may include:

• Mutual Funds: Large funds like Vanguard or Fidelity may hold shares of TELA as part of broader healthcare or small-cap portfolios. Their investment decisions are typically driven by the company's financial performance, growth prospects, and alignment with the fund's investment strategy.
• Hedge Funds: Hedge funds may take positions in TELA based on various factors, including perceived undervaluation, potential for short-term gains, or involvement in activist strategies. Their trading activity can sometimes lead to increased price volatility.
• Pension Funds: Pension funds invest for long-term growth and income. They may hold TELA shares as part of their diversified portfolios, contributing to the stock's stability.

Individual investors also play a role in TELA's stock ownership. These investors may range from retail traders to high-net-worth individuals with substantial portfolios. Their investment decisions can be influenced by factors such as personal investment goals, risk tolerance, and information from financial news and analysis.

Investor influence on TELA Bio, Inc. (TELA) can manifest in several ways:

• Stock Price: Large institutional investors buying or selling significant blocks of shares can impact the stock price. Positive news or strong financial results may attract more investors, driving the price up, while negative developments could lead to selling pressure.
• Company Decisions: Major shareholders may have the opportunity to influence company decisions through voting rights. They can vote on matters such as board elections, executive compensation, and significant corporate actions.
• Activist Strategies: Activist investors may seek to influence company strategy or management through public campaigns, proxy battles, or direct engagement with the board. Their goals may include improving operational efficiency, increasing shareholder value, or pursuing strategic alternatives.

Recent moves by key investors, such as acquiring or divesting large stakes in TELA Bio, Inc. (TELA), can signal their confidence (or lack thereof) in the company's future prospects. Monitoring these moves through financial news sources and regulatory filings can provide valuable insights for other investors.

For further insights into TELA Bio, Inc. (TELA)'s financial standing, see Breaking Down TELA Bio, Inc. (TELA) Financial Health: Key Insights for Investors.

TELA Bio, Inc. (TELA) Market Impact and Investor Sentiment

Understanding the investor profile and sentiment surrounding TELA Bio, Inc. (TELA) is crucial for assessing the company's market position and future prospects. Analyzing major shareholders' attitudes, recent market reactions, and analyst perspectives provides a comprehensive view of the factors influencing TELA's stock performance.

Investor Sentiment: The sentiment of major shareholders can significantly influence a stock's stability and direction. Positive sentiment typically leads to increased investment, driving up the stock price, while negative sentiment can cause sell-offs. Unfortunately, real-time sentiment data of major shareholders is dynamic and often proprietary. However, shifts in ownership percentages reported in SEC filings can offer clues. For example, an increase in holdings by institutional investors might suggest a positive outlook, while a decrease could indicate concerns about the company's performance or future prospects.

Recent Market Reactions: The stock market's response to changes in ownership or large investor moves can provide valuable insights into market confidence in TELA Bio, Inc. (TELA). Significant investments or divestments by institutional investors often trigger price fluctuations. Monitoring these reactions helps gauge the market's perception of the company's value and potential. Keep an eye on:

• Sudden price spikes: These may indicate a positive reaction to new investments or endorsements by prominent investors.
• Price drops: These could signal concerns following large sell-offs or negative assessments from major shareholders.

Analyst Perspectives: Financial analysts play a critical role in shaping investor sentiment through their research reports and ratings. These experts assess TELA Bio, Inc. (TELA)'s financial health, market opportunities, and competitive landscape to provide recommendations to investors. Analyst perspectives to consider:

• Buy ratings: These often attract new investors, driving up the stock price.
• Hold ratings: These suggest a neutral outlook, indicating that the stock is fairly valued.
• Sell ratings: These can lead to sell-offs, putting downward pressure on the stock price.

Moreover, analysts' price targets reflect their expectations for the stock's future performance, influencing short-term and long-term investment strategies. Monitoring these ratings and targets helps investors align their strategies with expert opinions and market expectations.

Here is an example of institutional ownership data, which is vital for understanding investor sentiment. Please note that the data below is illustrative and should be replaced with the most current information available from reputable financial data sources for TELA Bio, Inc. (TELA).

Keep track of how major institutional holders adjust their positions, as this can be a leading indicator of sentiment. Significant increases or decreases in their holdings can signal shifts in their confidence in the company's prospects.

For further insights into the company's financial standing, explore Breaking Down TELA Bio, Inc. (TELA) Financial Health: Key Insights for Investors.